AI insights company founded by Stanford professors raises $22M

An AI-enabled health insights company, Cardinal Analytx Solutions, has raised $22 million in a series B funding round.

The company, which was founded by Stanford professors Arnie Milstein, MD, and Nigam Shah, MBBS, PhD, integrates predictive insights with meaningful actions to find people at high risk of rising cost and worsening health, according to a press release. The platform matches people with interventions that can prevent further decline in their health. The proactive healthcare company was also founded in partnership with Cardinal Partners.

“Cardinal uses machine learning to create advanced, early-warning predictions and interventions to address health conditions early––when they matter most,” said John Doerr, who led the funding round and will also serve on Cardinal’s board of directors. He is also chairman of Kleiner Perkins.

Other investors include GuideWell Mutual Holding Corporation, Blue Shield of California and Premera Blue Cross. The company, which is based in Palo Alto, California, plans to use the capital to invest in talent and more technology.

“The caliber of investors we’ve attracted speaks for itself, validating our team’s efforts to execute on our vision: to deliver proactive healthcare that improves people’s health and reduces the total cost of care,” Cardinal Analytx CEO Linda T. Hand said in a statement.

The level of investment interest in the healthcare space continues to skyrocket, and the technology and healthcare IT recently identified as the richest investment opportunity by M&A professionals in the sector.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.